Flunitrazepam


w230



General information:


Withdrawn ID: w230
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): N05CD03
Molecular Formula: C16H12FN3O3
Molweight: 313.283



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1975
First withdrawn: 1996
Last withdrawn: 1996
Reference: https://dij.sagepub.com/content/35/1/293.full.pdf



Side-effects:

Total reported cases (submitted by medical professionals) with Flunitrazepam as primary suspect: 9


Reported final outcomes:
Hospitalization (initial or prolonged): 5
Life-Threatening condition: 1


Reported side-effects:

Side-effect Case number
Overdose4
Altered state of consciousness2
Drug withdrawal syndrome2
Toxicity to various agents2
Hallucination, visual2
Delirium2
Coma2
Dehydration1
COORDINATION ABNORMAL1
Delusion1
Disorientation1
DIZZINESS1
DRUG ABUSER1
Drug dependence1
Drug eruption1
DRUG INTERACTION1
DRUG LEVEL INCREASED1
ASTHENIA1
Hallucination, auditory1
GENERAL PHYSICAL HEALTH DETERIORATION1
Generalised tonic-clonic seizure1
Heart rate abnormal1
Hepatic function abnormal1
Hyporeflexia1
Hypotension1
Inflammation1
Intentional overdose1
LOSS OF CONSCIOUSNESS1
Neuroleptic malignant syndrome1
NYSTAGMUS1
Oxygen saturation decreased1
Pneumonia aspiration1
Respiratory disorder1
Rhabdomyolysis1
Suicide attempt1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P18507 1.4 Gamma-aminobutyric acid receptor subunit gamma-2 GBRG2_HUMAN



Toxicity information:

Toxicity class: 6
Toxicity type: multiple
LD50: 8687 mg/kg



External links:

ChEBML: CHEMBL13280
DrugBank: DB01544